MIRM

Mirum Pharmaceuticals, Inc. Common Stock
Data: 2026-07-31
$105.95
Price
-5.90%
Change
$130.00
52W High
$50.25
52W Low

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Quick Stats
Jul 31, 2026

58.6

AI Score

HOLD

0.61

Volume Ratio

Aug 05, 2026

Next Earnings

16

+ve Days (30d)

14

-ve Days (30d)

MIRM Stock Summary

Last updated Jul 31, 2026

MIRM is currently trading at $105.95, positioned above its 200-day moving average of $92.51, indicating a long-term uptrend. The stock has a 52-week range of $50.25 to $130.

Technical Analysis: The 50-day moving average stands at $109.37, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.591, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.087, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates MIRM at 58.6/100 with a HOLD recommendation.

MIRM (Mirum Pharmaceuticals, Inc. Common Stock) Indicators

Last updated Jul 31, 2026

Indicator Value
RSI(14) 39.591
CMF (20) 0.087
ROC (10) -10.862
ADX (14) 23.71
Indicator Value
MACD (12,26,9) -0.837
AROONOSC (14) -92.857
WILLAMS %R (14) -98.449
MFI (14) 37.172
MIRM Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

MIRM Price vs Max Options Open Interest
MIRM Max Change In Options Open Interest

MIRM Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MIRM Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MIRM Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MIRM Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Mirum Pharmaceuticals, Inc. Common Stock is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).

MIRM Moving Averages Analysis

Mirum Pharmaceuticals, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 31, 2026

MIRM (Mirum Pharmaceuticals, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jul 31, 2026

Days MA
10 112.81
20 117.69
30 117.4
50 109.37
100 102.73
200 92.51

MIRM Fundamental Analysis

P/E (Forward) 39.6825
P/E (Trailing) --
Market Cap ($) 6.9 billion
Earnings/Share ($) -14.21
Net Profit Margin (%) -1.4024
Dividend/Share ($) --
EPS Estimate Current Year ($) -14.24
EPS Estimate Next Year ($) -0.188
WallStreet Target Price ($) 146.50
Most Recent Quarter